Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Office of Regulatory Affairs Makeover Blends Domestic, International Work

This article was originally published in The Tan Sheet

Executive Summary

The reorganized ORA has eight new offices to better handle new legislative authorities and globalization of its regulated products; FDA expects to increase partnerships with other government officials and foreign entities.

Advertisement

Related Content

People In Brief: Soller consults, Sharaf joins AHPA, Perrigo hires Crabill, Villaraigosa advises Herbalife
People In Brief: Soller consults, Sharaf joins AHPA, Perrigo hires Crabill, Villaraigosa advises Herbalife
FDA Drug Shortage Staff Gets Higher Profile As New Reporting Requirements Begin
Generic Drugs Gain Status Boost Within CDER
ORA Lab Closings Cancelled But Reorganization Not Off The Table – Staffers

Topics

Advertisement
UsernamePublicRestriction

Register

PS106026

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel